Remote home monitoring for pregnancy complications
Part of Women’s health & pregnancy clinical trials.
This trial tests a remote digital care system to monitor your pregnancy at home if you have a complication that requires regular CTG (fetal heartbeat) checks. The goal is to see if this home monitoring is safe and accessible, reducing the need for hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are at least 24 weeks pregnant (with a single baby).
- You speak English, Dutch, Spanish, or Swedish.
- You have a pregnancy complication that needs your baby's heartbeat to be monitored (CTG).
- You do not have very high blood pressure that needs IV medicine, and you do not need immediate delivery within 48 hours.
- You are not currently bleeding, your baby's heartbeat looks normal, and you live within 30 minutes of a hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial lets you monitor your baby's heartbeat at home with a simple device instead of coming to the hospital each time. It's for women with certain high-risk pregnancy conditions who are 32 weeks or more along.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
This study tests if women with high-risk pregnancies can safely use a remote monitor at home instead of staying in the hospital. You would use a belly patch to send your baby's heart rate and your contractions to your care team.
This study tests if remote monitoring of your baby's heartbeat from home is a safe and effective option for high-risk pregnancies. It may reduce the need for frequent hospital visits.
This study tests whether checking certain pregnancy warning signs at home (with monitoring technology) can help manage high-risk pregnancies. It may allow closer follow-up while you stay at home, aiming to improve safety and decision-making.
This trial tests whether a home monitoring device linked to a telehealth platform can safely reduce the number of in-person fetal nonstress tests (NSTs) needed for pregnant people with certain conditions. It may help you by offering more convenient monitoring between 32 and 40 weeks of pregnancy.
Hear when a new Telemedicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.